Literature DB >> 1489091

Automated analysis of the pyridinium crosslinks of collagen in tissue and urine using solid-phase extraction and reversed-phase high-performance liquid chromatography.

D A Pratt1, Y Daniloff, A Duncan, S P Robins.   

Abstract

A fully automated method for assaying the collagen crosslinking amino acids, pyridinoline and deoxypyridinoline, in human urine samples or tissue hydrolysates is described. Samples were processed using a Gilson ASPEC system with solid-phase extraction of the crosslinks on columns containing 100 mg of microgranular cellulose. Introduction of an additional solvent step during sample preparation allowed direct analysis by reversed-phase HPLC and elimination of the drying step used previously in a manual method. Use of a synthetic pyridinoline derivative as internal standard enabled accurate quantification of the crosslinks by correcting for recoveries through the whole assay. Samples were analyzed in sequential mode with a total assay time of 30 min. The automated assay showed close correlation with the manual method for both free and total crosslink determinations in human urine (r > 0.97). Reproducibility was improved, as seen from replicate analyses of human urine (CV < 3% for automated pyridinoline measurement compared with 8-12% previously observed for the manual method). Crosslink excretion is the most useful marker of collagen degradation in metabolic bone diseases and arthritic disorders. The automated assay which has been developed is rapid, convenient, and reliable and will greatly facilitate the monitoring of urinary collagen crosslinks and their tissue levels in clinical investigations.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1489091     DOI: 10.1016/0003-2697(92)90519-d

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  14 in total

Review 1.  Diagnosis of postmenopausal osteoporosis: reviews in endocrine and metabolic disorders.

Authors:  A T Shields; C H Chesnut
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

2.  Seasonal differences in biochemical parameters of bone remodelling.

Authors:  A S Douglas; M H Miller; D M Reid; J D Hutchison; R W Porter; S P Robins
Journal:  J Clin Pathol       Date:  1996-04       Impact factor: 3.411

3.  Telomere length in leukocytes correlates with bone mineral density and is shorter in women with osteoporosis.

Authors:  A M Valdes; J B Richards; J P Gardner; R Swaminathan; M Kimura; L Xiaobin; A Aviv; T D Spector
Journal:  Osteoporos Int       Date:  2007-03-09       Impact factor: 4.507

4.  Biochemical markers of bone turnover: part I: biochemistry and variability.

Authors:  Markus J Seibel
Journal:  Clin Biochem Rev       Date:  2005-11

5.  Quantitative analysis of pyridinium crosslinks of collagen in the synovial fluid of patients with rheumatoid arthritis using high-performance liquid chromatography.

Authors:  A Müller; G Hein; S Franke; D Herrmann; S Henzgen; A Roth; G Stein
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

6.  Intravenous 1alpha, 25[OH]2 vitamin D3 (calcitriol) pulse therapy for bone lesions in a murine model of chronic cadmium toxicosis.

Authors:  Y Kurata; O Katsuta; H Hiratsuka; M Tsuchitani; T Umemura
Journal:  Int J Exp Pathol       Date:  2001-02       Impact factor: 1.925

7.  Evaluation of extraction methods for quantification of aqueous fullerenes in urine.

Authors:  Troy M Benn; Benny F G Pycke; Pierre Herckes; Paul Westerhoff; Rolf U Halden
Journal:  Anal Bioanal Chem       Date:  2010-12-12       Impact factor: 4.142

8.  Investigation of generalized osteoarthritis by combining X-ray grading of the knee, spine and hand using biochemical markers for arthritis in patients with knee osteoarthritis.

Authors:  Masashi Abe; Masaaki Takahashi; Kenichi Naitou; Kumiko Ohmura; Akira Nagano
Journal:  Clin Rheumatol       Date:  2003-11-13       Impact factor: 2.980

9.  Urinary excretion of the pyridinium cross-links of collagen in systemic lupus erythematosus.

Authors:  Y Kipen; R Will; B J Strauss; E F Morand
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

10.  A connective tissue disorder caused by mutations of the lysyl hydroxylase 3 gene.

Authors:  Antti M Salo; Helen Cox; Peter Farndon; Celia Moss; Helen Grindulis; Maija Risteli; Simon P Robins; Raili Myllylä
Journal:  Am J Hum Genet       Date:  2008-10-02       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.